SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019056-13-000425
Filing Date
2013-03-22
Accepted
2013-03-22 15:39:16
Documents
1
Period of Report
2010-03-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT reinisch_4.html 4  
1 OWNERSHIP DOCUMENT reinisch_4.xml 4 13567
  Complete submission text file 0001019056-13-000425.txt   14952
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4 BARRETT WOODS BALLWIN MO 63021
Business Address
Reinisch Richard (Reporting) CIK: 0001572691 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24274 | Film No.: 13711167